These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 20404632)

  • 1. Glucagon-like peptide-1: a kinder, gentler method to achieving glycemic control for critically ill patients?
    Dickerson RN
    Crit Care Med; 2010 May; 38(5):1379-80. PubMed ID: 20404632
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of exogenous glucagon-like peptide-1 on gastric emptying and glucose absorption in the critically ill: relationship to glycemia.
    Deane AM; Chapman MJ; Fraser RJ; Summers MJ; Zaknic AV; Storey JP; Jones KL; Rayner CK; Horowitz M
    Crit Care Med; 2010 May; 38(5):1261-9. PubMed ID: 20228679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoglycemia and strict glycemic control in critically ill patients.
    Vriesendorp TM; DeVries JH; Hoekstra JB
    Curr Opin Crit Care; 2008 Aug; 14(4):397-402. PubMed ID: 18614902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glucagon-like peptide-1 (GLP-1) on glycemic control and left ventricular function in patients undergoing coronary artery bypass grafting.
    Sokos GG; Bolukoglu H; German J; Hentosz T; Magovern GJ; Maher TD; Dean DA; Bailey SH; Marrone G; Benckart DH; Elahi D; Shannon RP
    Am J Cardiol; 2007 Sep; 100(5):824-9. PubMed ID: 17719327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evidence for achieving glycemic control with incretin mimetics.
    Drucker DJ
    Diabetes Educ; 2006; 32 Suppl 2():72S-81S. PubMed ID: 16554431
    [No Abstract]   [Full Text] [Related]  

  • 6. Glycemic variability: a strong independent predictor of mortality in critically ill patients.
    Krinsley JS
    Crit Care Med; 2008 Nov; 36(11):3008-13. PubMed ID: 18824908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoglycemia and cardiac arrest in a critically ill patient on strict glycemic control.
    Bhatia A; Cadman B; Mackenzie I
    Anesth Analg; 2006 Feb; 102(2):549-51. PubMed ID: 16428559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practice of strict glycemic control in critically ill patients.
    Schultz MJ; de Graaff MJ; Royakkers AA; van Braam Houckgeest F; van der Sluijs JP; Kieft H; Spronk PE
    Med Sci Monit; 2008 Nov; 14(11):RA191-7. PubMed ID: 18971884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood and tissue glucose level in critically ill patients: a comparison of different methods of measuring interstitial glucose levels.
    Vlkova A; Dostal P; Musil F; Smahelová A; Zadak Z; Cerny V
    Intensive Care Med; 2009 Jul; 35(7):1318. PubMed ID: 19238356
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucose control in the intensive care unit.
    Fahy BG; Sheehy AM; Coursin DB
    Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood glucose control in critically ill patients: the impact of diabetes.
    Krinsley JS
    Crit Care Med; 2009 Jan; 37(1):382; author reply 382-3. PubMed ID: 19112326
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1.
    Nauck MA; Walberg J; Vethacke A; El-Ouaghlidi A; Senkal M; Holst JJ; Gallwitz B; Schmidt WE; Schmiegel W
    Regul Pept; 2004 Apr; 118(1-2):89-97. PubMed ID: 14759561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point-of-care glucose testing in critically ill patients: visual logistics and a glycemic variability hypothesis.
    Kost GJ; Tran NK; Sifontes JR; Mecozzi DM; Louie RF; Abad VJ
    Crit Care Med; 2009 Oct; 37(10):2841-3. PubMed ID: 19865008
    [No Abstract]   [Full Text] [Related]  

  • 14. Intensive insulin therapy for critically ill patients.
    Lewis KS; Kane-Gill SL; Bobek MB; Dasta JF
    Ann Pharmacother; 2004; 38(7-8):1243-51. PubMed ID: 15187219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of glucagon-like peptide-1 to induce panic attacks or anxiety in patients with panic disorder.
    Strawn JR; D'Alessio DA; Keck PE; Seeley RJ
    J Psychiatr Res; 2008 Jul; 42(9):787-9. PubMed ID: 17888452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic beta-cell responses to GLP-1 after near-normalization of blood glucose in patients with type 2 diabetes.
    Asmar M; Højberg PV; Deacon CF; Hare K; Holst JJ; Madsbad S
    Regul Pept; 2010 Feb; 160(1-3):175-80. PubMed ID: 20005261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An insulin infusion protocol in critically ill cardiothoracic surgery patients.
    Zimmerman CR; Mlynarek ME; Jordan JA; Rajda CA; Horst HM
    Ann Pharmacother; 2004; 38(7-8):1123-9. PubMed ID: 15150382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.
    Van den Berghe G; Wouters PJ; Bouillon R; Weekers F; Verwaest C; Schetz M; Vlasselaers D; Ferdinande P; Lauwers P
    Crit Care Med; 2003 Feb; 31(2):359-66. PubMed ID: 12576937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian rhythm of blood glucose values in critically ill patients.
    Egi M; Bellomo R; Stachowski E; French CJ; Hart G; Stow P
    Crit Care Med; 2007 Feb; 35(2):416-21. PubMed ID: 17205020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing intravenous glucose load in the presence of normoglycemia: effect on outcome and metabolism in critically ill rabbits.
    Derde S; Vanhorebeek I; Ververs EJ; Vanhees I; Darras VM; Van Herck E; Larsson L; Van den Berghe G
    Crit Care Med; 2010 Feb; 38(2):602-11. PubMed ID: 19851097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.